Specialty Injectable Generics Market
1 Study Coverage
1.1 Specialty Injectable Generics Revenue in Specialty Injectable Generics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Specialty Injectable Generics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Specialty Injectable Generics Market Size for the Year 2017-2028
1.2.2 Global Specialty Injectable Generics Market Size for the Year 2017-2028
1.3 Specialty Injectable Generics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Specialty Injectable Generics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Specialty Injectable Generics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Specialty Injectable Generics Market Dynamics
1.4.1 Specialty Injectable Generics Industry Trends
1.4.2 Specialty Injectable Generics Market Drivers
1.4.3 Specialty Injectable Generics Market Challenges
1.4.4 Specialty Injectable Generics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Specialty Injectable Generics by Type
2.1 Specialty Injectable Generics Market Segment by Type
2.1.1 Type I
2.1.2 Type II
2.2 Global Specialty Injectable Generics Market Size by Type (2017, 2022 & 2028)
2.3 Global Specialty Injectable Generics Market Size by Type (2017-2028)
2.4 United States Specialty Injectable Generics Market Size by Type (2017, 2022 & 2028)
2.5 United States Specialty Injectable Generics Market Size by Type (2017-2028)
3 Specialty Injectable Generics by Application
3.1 Specialty Injectable Generics Market Segment by Application
3.1.1 Oncology
3.1.2 Cardiovascular
3.1.3 Central Nervous System
3.1.4 Infectious Diseases
3.1.5 Autoimmune Disorders
3.2 Global Specialty Injectable Generics Market Size by Application (2017, 2022 & 2028)
3.3 Global Specialty Injectable Generics Market Size by Application (2017-2028)
3.4 United States Specialty Injectable Generics Market Size by Application (2017, 2022 & 2028)
3.5 United States Specialty Injectable Generics Market Size by Application (2017-2028)
4 Global Specialty Injectable Generics Competitor Landscape by Company
4.1 Global Specialty Injectable Generics Market Size by Company
4.1.1 Top Global Specialty Injectable Generics Companies Ranked by Revenue (2021)
4.1.2 Global Specialty Injectable Generics Revenue by Player (2017-2022)
4.2 Global Specialty Injectable Generics Concentration Ratio (CR)
4.2.1 Specialty Injectable Generics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Specialty Injectable Generics in 2021
4.2.3 Global Specialty Injectable Generics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Specialty Injectable Generics Headquarters, Revenue in Specialty Injectable Generics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Specialty Injectable Generics Headquarters and Area Served
4.3.2 Global Specialty Injectable Generics Companies Revenue in Specialty Injectable Generics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Specialty Injectable Generics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Specialty Injectable Generics Market Size by Company
4.5.1 Top Specialty Injectable Generics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Specialty Injectable Generics Revenue by Players (2020, 2021 & 2022)
5 Global Specialty Injectable Generics Market Size by Region
5.1 Global Specialty Injectable Generics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Specialty Injectable Generics Market Size by Region (2017-2028)
5.2.1 Global Specialty Injectable Generics Market Size by Region: 2017-2022
5.2.2 Global Specialty Injectable Generics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Specialty Injectable Generics Market Size YoY Growth 2017-2028
6.1.2 North America Specialty Injectable Generics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Specialty Injectable Generics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Specialty Injectable Generics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Specialty Injectable Generics Market Size YoY Growth 2017-2028
6.3.2 Europe Specialty Injectable Generics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Specialty Injectable Generics Market Size YoY Growth 2017-2028
6.4.2 Latin America Specialty Injectable Generics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Specialty Injectable Generics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Specialty Injectable Generics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Details
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Specialty Injectable Generics Introduction
7.1.4 Pfizer Revenue in Specialty Injectable Generics Business (2017-2022)
7.1.5 Pfizer Recent Development
7.2 Fresenius
7.2.1 Fresenius Company Details
7.2.2 Fresenius Business Overview
7.2.3 Fresenius Specialty Injectable Generics Introduction
7.2.4 Fresenius Revenue in Specialty Injectable Generics Business (2017-2022)
7.2.5 Fresenius Recent Development
7.3 Mylan
7.3.1 Mylan Company Details
7.3.2 Mylan Business Overview
7.3.3 Mylan Specialty Injectable Generics Introduction
7.3.4 Mylan Revenue in Specialty Injectable Generics Business (2017-2022)
7.3.5 Mylan Recent Development
7.4 Teva Pharmaceutical
7.4.1 Teva Pharmaceutical Company Details
7.4.2 Teva Pharmaceutical Business Overview
7.4.3 Teva Pharmaceutical Specialty Injectable Generics Introduction
7.4.4 Teva Pharmaceutical Revenue in Specialty Injectable Generics Business (2017-2022)
7.4.5 Teva Pharmaceutical Recent Development
7.5 Hikma Pharmaceuticals
7.5.1 Hikma Pharmaceuticals Company Details
7.5.2 Hikma Pharmaceuticals Business Overview
7.5.3 Hikma Pharmaceuticals Specialty Injectable Generics Introduction
7.5.4 Hikma Pharmaceuticals Revenue in Specialty Injectable Generics Business (2017-2022)
7.5.5 Hikma Pharmaceuticals Recent Development
7.6 Novartis
7.6.1 Novartis Company Details
7.6.2 Novartis Business Overview
7.6.3 Novartis Specialty Injectable Generics Introduction
7.6.4 Novartis Revenue in Specialty Injectable Generics Business (2017-2022)
7.6.5 Novartis Recent Development
7.7 Uman Pharma
7.7.1 Uman Pharma Company Details
7.7.2 Uman Pharma Business Overview
7.7.3 Uman Pharma Specialty Injectable Generics Introduction
7.7.4 Uman Pharma Revenue in Specialty Injectable Generics Business (2017-2022)
7.7.5 Uman Pharma Recent Development
7.8 Baxter
7.8.1 Baxter Company Details
7.8.2 Baxter Business Overview
7.8.3 Baxter Specialty Injectable Generics Introduction
7.8.4 Baxter Revenue in Specialty Injectable Generics Business (2017-2022)
7.8.5 Baxter Recent Development
7.9 Par Pharmaceutical
7.9.1 Par Pharmaceutical Company Details
7.9.2 Par Pharmaceutical Business Overview
7.9.3 Par Pharmaceutical Specialty Injectable Generics Introduction
7.9.4 Par Pharmaceutical Revenue in Specialty Injectable Generics Business (2017-2022)
7.9.5 Par Pharmaceutical Recent Development
7.10 Sagent Pharmaceuticals
7.10.1 Sagent Pharmaceuticals Company Details
7.10.2 Sagent Pharmaceuticals Business Overview
7.10.3 Sagent Pharmaceuticals Specialty Injectable Generics Introduction
7.10.4 Sagent Pharmaceuticals Revenue in Specialty Injectable Generics Business (2017-2022)
7.10.5 Sagent Pharmaceuticals Recent Development
7.11 Teligent
7.11.1 Teligent Company Details
7.11.2 Teligent Business Overview
7.11.3 Teligent Specialty Injectable Generics Introduction
7.11.4 Teligent Revenue in Specialty Injectable Generics Business (2017-2022)
7.11.5 Teligent Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Specialty Injectable Generics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Specialty Injectable Generics Market Trends
Table 3. Specialty Injectable Generics Market Drivers
Table 4. Specialty Injectable Generics Market Challenges
Table 5. Specialty Injectable Generics Market Restraints
Table 6. Global Specialty Injectable Generics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Specialty Injectable Generics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Specialty Injectable Generics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Specialty Injectable Generics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Specialty Injectable Generics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Specialty Injectable Generics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Specialty Injectable Generics Revenue Share by Player, 2017-2022
Table 13. Global Specialty Injectable Generics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Specialty Injectable Generics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specialty Injectable Generics as of 2021)
Table 15. Top Players of Specialty Injectable Generics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Specialty Injectable Generics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Specialty Injectable Generics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Specialty Injectable Generics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Specialty Injectable Generics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Specialty Injectable Generics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Specialty Injectable Generics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Specialty Injectable Generics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Specialty Injectable Generics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Specialty Injectable Generics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Specialty Injectable Generics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Specialty Injectable Generics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Specialty Injectable Generics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Specialty Injectable Generics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Pfizer Company Details
Table 31. Pfizer Business Overview
Table 32. Pfizer Specialty Injectable Generics Product
Table 33. Pfizer Revenue in Specialty Injectable Generics Business (2017-2022) & (US$ Million)
Table 34. Pfizer Recent Development
Table 35. Fresenius Company Details
Table 36. Fresenius Business Overview
Table 37. Fresenius Specialty Injectable Generics Product
Table 38. Fresenius Revenue in Specialty Injectable Generics Business (2017-2022) & (US$ Million)
Table 39. Fresenius Recent Development
Table 40. Mylan Company Details
Table 41. Mylan Business Overview
Table 42. Mylan Specialty Injectable Generics Product
Table 43. Mylan Revenue in Specialty Injectable Generics Business (2017-2022) & (US$ Million)
Table 44. Mylan Recent Development
Table 45. Teva Pharmaceutical Company Details
Table 46. Teva Pharmaceutical Business Overview
Table 47. Teva Pharmaceutical Specialty Injectable Generics Product
Table 48. Teva Pharmaceutical Revenue in Specialty Injectable Generics Business (2017-2022) & (US$ Million)
Table 49. Teva Pharmaceutical Recent Development
Table 50. Hikma Pharmaceuticals Company Details
Table 51. Hikma Pharmaceuticals Business Overview
Table 52. Hikma Pharmaceuticals Specialty Injectable Generics Product
Table 53. Hikma Pharmaceuticals Revenue in Specialty Injectable Generics Business (2017-2022) & (US$ Million)
Table 54. Hikma Pharmaceuticals Recent Development
Table 55. Novartis Company Details
Table 56. Novartis Business Overview
Table 57. Novartis Specialty Injectable Generics Product
Table 58. Novartis Revenue in Specialty Injectable Generics Business (2017-2022) & (US$ Million)
Table 59. Novartis Recent Development
Table 60. Uman Pharma Company Details
Table 61. Uman Pharma Business Overview
Table 62. Uman Pharma Specialty Injectable Generics Product
Table 63. Uman Pharma Revenue in Specialty Injectable Generics Business (2017-2022) & (US$ Million)
Table 64. Uman Pharma Recent Development
Table 65. Baxter Company Details
Table 66. Baxter Business Overview
Table 67. Baxter Specialty Injectable Generics Product
Table 68. Baxter Revenue in Specialty Injectable Generics Business (2017-2022) & (US$ Million)
Table 69. Baxter Recent Development
Table 70. Par Pharmaceutical Company Details
Table 71. Par Pharmaceutical Business Overview
Table 72. Par Pharmaceutical Specialty Injectable Generics Product
Table 73. Par Pharmaceutical Revenue in Specialty Injectable Generics Business (2017-2022) & (US$ Million)
Table 74. Par Pharmaceutical Recent Development
Table 75. Sagent Pharmaceuticals Company Details
Table 76. Sagent Pharmaceuticals Business Overview
Table 77. Sagent Pharmaceuticals Specialty Injectable Generics Product
Table 78. Sagent Pharmaceuticals Revenue in Specialty Injectable Generics Business (2017-2022) & (US$ Million)
Table 79. Sagent Pharmaceuticals Recent Development
Table 80. Teligent Company Details
Table 81. Teligent Business Overview
Table 82. Teligent Specialty Injectable Generics Product
Table 83. Teligent Revenue in Specialty Injectable Generics Business (2017-2022) & (US$ Million)
Table 84. Teligent Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
List of Figures
Figure 1. Specialty Injectable Generics Product Picture
Figure 2. Global Specialty Injectable Generics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Specialty Injectable Generics Market Size 2017-2028 (US$ Million)
Figure 4. United States Specialty Injectable Generics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Specialty Injectable Generics Market Size 2017-2028 (US$ Million)
Figure 6. United States Specialty Injectable Generics Market Share in Global 2017-2028
Figure 7. Specialty Injectable Generics Report Years Considered
Figure 8. Product Picture of Type I
Figure 9. Product Picture of Type II
Figure 10. Global Specialty Injectable Generics Market Share by Type in 2022 & 2028
Figure 11. Global Specialty Injectable Generics Market Size by Type (2017-2028) & (US$ Million)
Figure 12. Global Specialty Injectable Generics Market Share by Type (2017-2028)
Figure 13. United States Specialty Injectable Generics Market Share by Type in 2022 & 2028
Figure 14. United States Specialty Injectable Generics Market Size by Type (2017-2028) & (US$ Million)
Figure 15. United States Specialty Injectable Generics Market Share by Type (2017-2028)
Figure 16. Product Picture of Oncology
Figure 17. Product Picture of Cardiovascular
Figure 18. Product Picture of Central Nervous System
Figure 19. Product Picture of Infectious Diseases
Figure 20. Product Picture of Autoimmune Disorders
Figure 21. Global Specialty Injectable Generics Market Share by Application in 2022 & 2028
Figure 22. Global Specialty Injectable Generics Market Size by Application (2017-2028) & (US$ Million)
Figure 23. Global Specialty Injectable Generics Market Share by Application (2017-2028)
Figure 24. United States Specialty Injectable Generics Market Share by Application in 2022 & 2028
Figure 25. United States Specialty Injectable Generics Market Size by Application (2017-2028) & (US$ Million)
Figure 26. United States Specialty Injectable Generics Market Share by Application (2017-2028)
Figure 27. North America Specialty Injectable Generics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 28. U.S. Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Canada Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Europe Specialty Injectable Generics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 31. Germany Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. France Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. U.K. Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Italy Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Russia Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Specialty Injectable Generics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 37. China Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Japan Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. South Korea Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. India Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Australia Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Taiwan Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Indonesia Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Thailand Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Malaysia Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Philippines Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Latin America Specialty Injectable Generics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 48. Mexico Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Brazil Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Argentina Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Specialty Injectable Generics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 52. Turkey Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. U.A.E Specialty Injectable Generics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Pfizer Revenue Growth Rate in Specialty Injectable Generics Business (2017-2022)
Figure 56. Fresenius Revenue Growth Rate in Specialty Injectable Generics Business (2017-2022)
Figure 57. Mylan Revenue Growth Rate in Specialty Injectable Generics Business (2017-2022)
Figure 58. Teva Pharmaceutical Revenue Growth Rate in Specialty Injectable Generics Business (2017-2022)
Figure 59. Hikma Pharmaceuticals Revenue Growth Rate in Specialty Injectable Generics Business (2017-2022)
Figure 60. Novartis Revenue Growth Rate in Specialty Injectable Generics Business (2017-2022)
Figure 61. Uman Pharma Revenue Growth Rate in Specialty Injectable Generics Business (2017-2022)
Figure 62. Baxter Revenue Growth Rate in Specialty Injectable Generics Business (2017-2022)
Figure 63. Par Pharmaceutical Revenue Growth Rate in Specialty Injectable Generics Business (2017-2022)
Figure 64. Sagent Pharmaceuticals Revenue Growth Rate in Specialty Injectable Generics Business (2017-2022)
Figure 65. Teligent Revenue Growth Rate in Specialty Injectable Generics Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Industry Market Size
